Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Founded in 2021, Isomorphic Labs is a subsidiary of Google parent Alphabet. It is currently preparing to dose the first patients with the AI-engineered drug in clinical trials and is “staffing up” ...

Google DeepMind CEO Demis Hassabis has said that AI can have a serious crack at solving all diseases in the coming years. And ...

Trump’s new COVID-19 website features five arguments supporting the lab. Among them was the explanation that Wuhan – the Chinese city where the virus first began spreading – is home to a ...

To me, the deal with OpenAI is a transformative game changer for Alphabet in the long run and I see the stock as a no-brainer buy right now. Should you invest $1,000 in Alphabet right now?

This week, Mint unlocks Perplexity Labs—an AI-powered tool that can turn messy user feedback into clear, actionable insights.

Monorepo of isomorphic utility functions This library is meant to replace all global JavaScript functions with isomorphic module imports. Additionally, it implements several performance-oriented ...

Chutes & Ladders— BMS banks on Wall Street vet for long-term strategy guidance By Darren Incorvaia, Zoey Becker Jun 20, 2025 8:30am Chutes and Ladders Bristol Myers Squibb CBER Isomorphic Labs ...

Isomorphic Labs, an AI-first drug discovery company, has announced the appointment of Ben B. Wolf as chief medical officer. Dr. Wolf will be based in the company's newly established Cambridge location ...

Explore the exciting world of Alphabet (GOOG -0.43%) (GOOGL -1.19%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market ...